The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled by rising R&D efforts, increasing demand for tailored antibodies, broader ...
insights from industryDr. Zhang Lin LinTechnical SpecialistSino Biological Europe In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding ...
The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...
Antibody production companies are essential in dealing with the growing demand for antibodies for life sciences, therapeutic, and diagnostic applications. Therefore, a number of service providers are ...
CHICAGO, June 5, 2024 /PRNewswire/ -- Custom Antibody Market in terms of revenue was estimated to be worth $579 million in 2024 and is poised to reach $901 million by 2029, growing at a CAGR of 9.2% ...
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related ...
In 1975, Georges Köhler and César Milstein, biochemists from the Medical Research Council Laboratory of Molecular Biology, published a paper in Nature about a hybridoma technology that enabled the ...
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback